The mechanism and regulation of mRNA recruitment during eukaryotic translation initiation
真核翻译起始过程中mRNA招募的机制和调控
基本信息
- 批准号:10578362
- 负责人:
- 金额:$ 36.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-19 至 2027-11-30
- 项目状态:未结题
- 来源:
- 关键词:AffinityAntineoplastic AgentsBindingBinding ProteinsBiochemicalBiological AssayBiophysicsCell ExtractsComplexCryoelectron MicroscopyDataDefectDevelopmentDiscriminationDrug TargetingDrug resistanceEukaryotaEukaryotic Initiation Factor-1Eukaryotic Initiation FactorsEventExhibitsFDA approvedFluorescence MicroscopyFutureGene ExpressionHandHumanIn VitroIndividualInitiator CodonInitiator tRNALabelLaboratoriesLengthLettersLinkMaintenanceMalignant NeoplasmsMeasuresMediatingMessenger RNAModelingMolecularNeoplasm MetastasisOncogenicPathogenesisPhysiologicalPositioning AttributePreparationPrincipal InvestigatorProcessProteinsReagentRecombinantsRegulationResolutionRibosomal ProteinsRibosomesRoleSaccharomyces cerevisiaeSeriesSignal TransductionSiteSpecificityStructureSystemTextTherapeuticTimeTranslatingTranslation InitiationTranslationsTumor-DerivedYeastsanti-cancer therapeuticcancer therapydata exchangeeukaryotic initiation factor-5Bfluorophoremutantoverexpressionpolyadenosinepublic health relevancereconstitutionrecruitsingle moleculesingle-molecule FRETtime usetumor growthtumorigenesis
项目摘要
PROJECT SUMMARY
The efficiency with which messenger RNAs (mRNAs) are translated into proteins by the ribosome is a
fundamental determinant of gene expression. This efficiency is often determined during the mRNA recruitment
step of translation by the ribosome. Consequently, this step is a crucial point of control for gene expression. In
eukaryotes, mRNA recruitment is an elaborate, multi-step, and highly regulated process that depends upon the
activities of ~13 eukaryotic initiation factors (eIFs). Dysregulation of eIF activity and mRNA recruitment has been
causally linked to tumorigenesis, tumor growth, drug resistance, and metastasis in an increasing list of human
cancers. Consequently, several eIFs and their roles in mRNA recruitment are emerging as very attractive
anticancer drug targets, with an existing, FDA-approved, eIF-targeting compound already having been
successfully repurposed as an anticancer therapy. In order to expand and fully exploit this therapeutic potential,
however, it is necessary to understand the molecular events that underlie eIF function and mRNA recruitment.
Here, we will use a highly purified, fluorophore-labeled, Saccharomyces cerevisiae in vitro translation
system that we developed and that includes a full-length, site-specifically labeled eIF4G and a fully reconstituted,
site-specifically labeled eIF3, reagents that have been difficult to generate. With these reagents in hand, we will
use state-of-the-art, single-molecule fluorescence microscopy and cryogenic electron microscopy (cryo-EM),
including a pioneering, time-resolved cryo-EM approach developed by our collaborator, Dr. Joachim Frank, to
directly observe and characterize the dynamics of mRNA recruitment during eukaryotic translation initiation.
In Aim 1, we will investigate the mechanism through which the multi-component eIF4F complex activates
different classes of mRNAs for loading onto ribosomal 43S pre-initiation complexes (PICs), and how changes to
the composition of the eIF4F complex can alter which classes of mRNAs are activated. We hypothesize that the
structural dynamics of the activated mRNA complex are critical for mRNA loading and will quantify how these
dynamics contribute to mRNA selection. In Aim 2, we will investigate how the multi-component eIF3 complex
interacts with different classes of mRNAs and/or the 43S PIC in order to facilitate mRNA activation and/or loading
onto a 43S PIC, as well as how biologically active subcomplexes of eIF3 can modulate these activities. A large-
scale structural rearrangement of 43S PIC-bound eIF3 is thought to control its mRNA loading activity and we will
therefore characterize how this rearrangement facilitates formation of the 48S PIC on mRNAs of different
classes. In Aim 3, we will investigate the mechanism through which eIF1A and eIF5B mediate mRNA start-codon
recognition within a 48S PIC. Start-codon recognition by eIF1A has recently been associated with a large-scale
rearrangement of the 48S PIC in which eIF5B and initiator transfer RNA (Met-tRNAi) are repositioned in
preparation for joining of the large subunit to the 48S PIC to form the elongation-competent 80S IC. We will
characterize these 48S PIC dynamics and determine their role in start-codon recognition and subunit joining.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruben L Gonzalez其他文献
Ruben L Gonzalez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ruben L Gonzalez', 18)}}的其他基金
Dynamics and mechanism of sodium-dependent carboxylate transporters
钠依赖性羧酸转运蛋白的动力学和机制
- 批准号:
10577283 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
Combined Optical Tweezers-Fluorescence Super-Resolution Microscope for Single-Molecule Biophysical Studies
用于单分子生物物理研究的光镊-荧光超分辨率组合显微镜
- 批准号:
10177000 - 财政年份:2021
- 资助金额:
$ 36.34万 - 项目类别:
The structural dynamics of ribosomal frameshifting and ribosome rescue
核糖体移码和核糖体拯救的结构动力学
- 批准号:
10377976 - 财政年份:2020
- 资助金额:
$ 36.34万 - 项目类别:
The structural dynamics of ribosomal frameshifting and ribosome rescue
核糖体移码和核糖体拯救的结构动力学
- 批准号:
10578684 - 财政年份:2020
- 资助金额:
$ 36.34万 - 项目类别:
Studies of Riboswitch-Mediated Transcriptional Control Using Single-Molecule Fiel
利用单分子场进行核糖开关介导的转录控制的研究
- 批准号:
8695928 - 财政年份:2014
- 资助金额:
$ 36.34万 - 项目类别:
Studies of Riboswitch-Mediated Transcriptional Control Using Single-Molecule Fiel
利用单分子场进行核糖开关介导的转录控制的研究
- 批准号:
8860202 - 财政年份:2014
- 资助金额:
$ 36.34万 - 项目类别:
The Structural Dynamics of Translation Initiation
翻译起始的结构动力学
- 批准号:
10011816 - 财政年份:2008
- 资助金额:
$ 36.34万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 36.34万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 36.34万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 36.34万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 36.34万 - 项目类别:














{{item.name}}会员




